These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10673095)

  • 21. Activation of striatal group II metabotropic glutamate receptors has a differential effect on dopamine-D1 and -D2 receptor antagonist-induced hypokinesia in the rat.
    Kronthaler UO; Schmidt WJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):289-97. PubMed ID: 10731042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of group III metabotropic glutamate receptors by hydrogen ions.
    Levinthal C; Barkdull L; Jacobson P; Storjohann L; Van Wagenen BC; Stormann TM; Hammerland LG
    Pharmacology; 2009; 83(2):88-94. PubMed ID: 19065062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of electrostatic interaction in the molecular recognition of selective agonists to metabotropic glutamate receptors.
    Macchiarulo A; Costantino G; Sbaglia R; Aiello S; Meniconi M; Pellicciari R
    Proteins; 2003 Mar; 50(4):609-19. PubMed ID: 12577267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Arg(78) in the metabotropic glutamate receptor mGlu(1) for agonist binding and selectivity.
    Jensen AA; Sheppard PO; O'Hara PJ; Krogsgaard-Larsen P; Bräuner-Osborne H
    Eur J Pharmacol; 2000 Jun; 397(2-3):247-53. PubMed ID: 10844121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells.
    Wroblewska B; Wroblewski JT; Pshenichkin S; Surin A; Sullivan SE; Neale JH
    J Neurochem; 1997 Jul; 69(1):174-81. PubMed ID: 9202308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and pharmacological characterization of all sixteen stereoisomers of 2-(2'-carboxy-3'-phenylcyclopropyl)glycine. Focus on (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a novel and selective group II metabotropic glutamate receptors antagonist.
    Pellicciari R; Marinozzi M; Natalini B; Costantino G; Luneia R; Giorgi G; Moroni F; Thomsen C
    J Med Chem; 1996 May; 39(11):2259-69. PubMed ID: 8667369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of metabotropic glutamate receptor antagonists on bursting activity in the amygdala.
    Keele NB; Neugebauer V; Shinnick-Gallagher P
    J Neurophysiol; 1999 May; 81(5):2056-65. PubMed ID: 10322047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational design and enantioselective synthesis of (1R,4S,5R,6S)-3-azabicyclo[3.3.0]octane-4,6-dicarboxylic acid - a novel inhibitor at human glutamate transporter subtypes 1, 2, and 3.
    Bunch L; Nielsen B; Jensen AA; Bräuner-Osborne H
    J Med Chem; 2006 Jan; 49(1):172-8. PubMed ID: 16392801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Among the twenty classical L-amino acids, only glutamate directly activates metabotropic glutamate receptors.
    Frauli M; Neuville P; Vol C; Pin JP; Prézeau L
    Neuropharmacology; 2006 Feb; 50(2):245-53. PubMed ID: 16310227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the metabotropic glutamate receptor mGluR5 prevents glutamate toxicity in primary cultures of cerebellar neurons.
    Montoliu C; Llansola M; Cucarella C; Grisolía S; Felipo V
    J Pharmacol Exp Ther; 1997 May; 281(2):643-7. PubMed ID: 9152368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enantioselective total synthesis of (1R,3S,4R,5R)-1-amino-4,5-dihydroxycyclopentane-1,3-dicarboxylic acid. A full-aldol access to carbaketose derivatives.
    Battistini L; Curti C; Zanardi F; Rassu G; Auzzas L; Casiraghi G
    J Org Chem; 2004 Apr; 69(7):2611-3. PubMed ID: 15049672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of single nucleotide polymorphisms of the human metabotropic glutamate receptor 1 gene and pharmacological characterization of a P993S variant.
    Downey PM; Petrò R; Simon JS; Devlin D; Lozza G; Veltri A; Beltramo M; Bertorelli R; Reggiani A
    Biochem Pharmacol; 2009 Apr; 77(7):1246-53. PubMed ID: 19146831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of phospholipases C and D by the novel metabotropic glutamate receptor agonist tADA.
    Klein J; Reymann KG; Riedel G
    Neuropharmacology; 1997 Feb; 36(2):261-3. PubMed ID: 9144664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pharmacological characterization of the mGluR1 alpha subtype of the metabotropic glutamate receptor expressed in a cloned baby hamster kidney cell line.
    Thomsen C; Mulvihill ER; Haldeman B; Pickering DS; Hampson DR; Suzdak PD
    Brain Res; 1993 Aug; 619(1-2):22-8. PubMed ID: 7690672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
    Nakazato A; Kumagai T; Sakagami K; Yoshikawa R; Suzuki Y; Chaki S; Ito H; Taguchi T; Nakanishi S; Okuyama S
    J Med Chem; 2000 Dec; 43(25):4893-909. PubMed ID: 11123999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and analysis of 4-(3-fluoropropyl)-glutamic acid stereoisomers to determine the stereochemical purity of (4S)-4-(3-[18F]fluoropropyl)-L-glutamic acid ([18F]FSPG) for clinical use.
    Shih KT; Huang YY; Yang CY; Cheng MF; Tien YW; Shiue CY; Yen RF; Hsin LW
    PLoS One; 2020; 15(12):e0243831. PubMed ID: 33315962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential actions of 3-(4-chlorophenyl) glutamic acid stereoisomers and L-trans-pyrrolidine-2,4-dicarboxylic acid upon L-homocysteic acid- and L-glutamic acid-induced responses from rat spinal motoneurones.
    Chalmers DJ; Jane DE; Sunter DC; Thompson GA; Udvarhelyi PM; Kilpatrick IC; Watkins JC
    Neuropharmacology; 1995 Dec; 34(12):1589-95. PubMed ID: 8788956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New analogues of ACPD with selective activity for group II metabotropic glutamate receptors.
    Bräuner-Osborne H; Madsen U; Mikiciuk-Olasik E; Curry K
    Eur J Pharmacol; 1997 Aug; 332(3):327-31. PubMed ID: 9300268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and studies on the mGluR agonist activity of FAP4 stereoisomers.
    Ivashkin P; Lemonnier G; Tora AS; Pin JP; Goudet C; Jubault P; Pannecoucke X
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2523-6. PubMed ID: 25958247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.